FindMyKOL

Deepa Kudalkar, MD

Basic profile

Cincinnati Children's Hospital Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionCincinnati, OH · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLFindMyKOL type: RegionalLatest publication2011Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Deepa Kudalkar is a Rheumatology/Immunology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 8 publications with 271 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Publications indexed by OpenAlex. Counts exclude supporting files.

271citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • ABBVIE INC.
    Program year202519 payments
    $251
  • Amgen Inc.
    Program year20252 payments
    $154
  • Janssen Scientific Affairs, LLC
    Program year20251 payment
    $109
All 8 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    51.4%
    RANK Ligand Inhibitor46.8%
    Denosumab99%Prolia1%
    Part D + Part B≥24 patients
    Xanthine oxidase inhibitor2.3%
    Allopurinol100%
    Part D≥29 patients

    + 4 more classes in this area

  • Cancer & immunology

    14.8%
    Folate Analog Metabolic Inhibitor7.5%
    Methotrexate100%
    Part D≥100 patients
    TNF inhibitor2.6%
    Humira(Cf) Pen58%Enbrel Sureclick34%Cimzia8%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    12.7%
    Corticosteroid7.3%
    Prednisone100%
    Part D≥127 patients
    Aminosalicylate3.2%
    Sulfasalazine100%
    Part D≥45 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”